Key Reasons to Add Crown Castle Stock to Your Portfolio Now — Positive

CCI   Zacks Investment Research — December 23, 2025

CCI is positioned to benefit from rising wireless data demand, long-term carrier leases and a solid balance sheet supporting network expansion.

image for news Key Reasons to Add Crown Castle Stock to Your Portfolio Now

Gold firmer, silver sharply up; both hit new record highs — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  SIL  SILJ  SIVR  SLV  SLVP  UGL   Kitco — December 23, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold firmer, silver sharply up; both hit new record highs

Novo Nordisk Wins FDA Nod for Oral Wegovy in Obesity, Stock Up — Positive

NVO   Zacks Investment Research — December 23, 2025

NVO stock up as it wins FDA approval for oral Wegovy in obesity, becoming the first oral GLP-1 RA indicated for weight management.

image for news Novo Nordisk Wins FDA Nod for Oral Wegovy in Obesity, Stock Up

Ford or General Motors: Which Stock to Buy Heading into 2026? — Positive

F  GM   Zacks Investment Research — December 23, 2025

GM's U.S. leadership, China rebound, software growth and aggressive buybacks give it an edge over Ford as 2026 approaches.

image for news Ford or General Motors: Which Stock to Buy Heading into 2026?

COIN to Buy Clearing Company: Is it Raising Prediction Market Stake? — Neutral

COIN   Zacks Investment Research — December 23, 2025

COIN to acquire The Clearing Company as it deepens its move into prediction markets and diversifies beyond crypto trading.

image for news COIN to Buy Clearing Company: Is it Raising Prediction Market Stake?

Why Ichor's 2026 Recovery Is Underestimated — Positive

ICHR   Seeking Alpha — December 23, 2025

Ichor Holdings (ICHR) is rated BUY, with fundamentals expected to improve in 2026 and a bottoming share price creating an attractive entry point. ICHR's new CEO is focused on operational discipline and margin expansion, leveraging proprietary products and a robust M&A strategy supported by prudent leverage. Revenue growth from key customers Lam Research and Applied Materials is projected to accelerate ICHR's production and gross margins toward historical levels.

image for news Why Ichor's 2026 Recovery Is Underestimated

Could Novo Nordisk's New Weight-Loss Pill Be Just What Its Stock Needs? — Positive

NVO   Investopedia — December 23, 2025

Could a new weight-loss pill be just what Novo Nordisk (NVO) needs to revive its stock?

image for news Could Novo Nordisk's New Weight-Loss Pill Be Just What Its Stock Needs?

3 Self-Driving Tech Stocks to Ride into 2026 as AV Race Heats Up — Neutral

BIDU  GOOG  UBER   Zacks Investment Research — December 23, 2025

BIDU, GOOGL and UBER are steering into 2026 with bold AV bets as the race to scale robotaxis globally intensifies.

image for news 3 Self-Driving Tech Stocks to Ride into 2026 as AV Race Heats Up

GILD Exercises Option to License Assembly Bio's Herpes Programs — Neutral

GILD   Zacks Investment Research — December 23, 2025

Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.

image for news GILD Exercises Option to License Assembly Bio's Herpes Programs

The plaintiff's law firm said was the largest-ever sum awarded against J&J for a single plaintiff.

image for news J&J ordered to pay record $1.5B in talc cancer lawsuit — while vowing to appeal ‘unconstitutional' ruling

New York, NY, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a premier investment banking firm, today announced that Hyperscale Data, Inc. (NYSE American: GPUS) has entered into a sales agreement under which Spartan Capital Securities will act as the Company's sales agent for an at-the-market equity offering program.

image for news Spartan Capital Securities, LLC Serves as Sales Agent in Hyperscale Data, Inc.'s $50 Million At-the-Market Offering

SLF Stock Near 52-Week High: Time to Hold Despite Expensive Valuation? — Positive

SLF   Zacks Investment Research — December 23, 2025

Sun Life Financial stock gains from growing asset management businesses, its focus on Asia operations, as well as scaling up and integrating U.S. operations.

image for news SLF Stock Near 52-Week High: Time to Hold Despite Expensive Valuation?

2 Stocks for You to Buy From the Growing Outsourcing Market — Neutral

CGEMY  TNET   Zacks Investment Research — December 23, 2025

The rising demand for BPO, AI and ML drives the Zacks Outsourcing industry's growth. Increasing cybersecurity risks demand more outsourcing options.

image for news 2 Stocks for You to Buy From the Growing Outsourcing Market

RADNOR, Pa. , Dec. 23, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").

image for news CarMax, Inc. Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit was filed on December 22, 2024 in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

image for news Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP)

Gold Mining ETF (GDXJ) Hits New 52-Week High — Neutral

GDXJ   Zacks Investment Research — December 23, 2025

GDXJ just broke to a new 52-week high as as gold demand surges on Fed rate-cut expectations, central bank buying and economic uncertainties.

image for news Gold Mining ETF (GDXJ) Hits New 52-Week High

CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies — Positive

CRSP   Zacks Investment Research — December 23, 2025

CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.

image for news CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies

Altria vs. Philip Morris: Who Leads Tobacco's Next Chapter? — Positive

MO  PM   Zacks Investment Research — December 23, 2025

MO and PM push smoke-free growth, using pricing power, innovation and discipline to navigate declining cigarette demand and reshape tobacco's future.

image for news Altria vs. Philip Morris: Who Leads Tobacco's Next Chapter?

Alibaba Stock Plunges 14.4% in 3 Months: Time to Buy, Sell or Hold? — Negative

BABA   Zacks Investment Research — December 23, 2025

BABA shares slides 14.4% in three months as profits crater despite revenue growth, with heavy AI and cloud spending testing investor patience.

image for news Alibaba Stock Plunges 14.4% in 3 Months: Time to Buy, Sell or Hold?

Bristol-Myers Squibb Company has rebounded solidly, as the market finally recognizes prior pessimism was excessive, driving renewed investor interest. Despite an estimated >60% revenue facing loss of exclusivity risks, BMY's growth portfolio delivered 18% growth in Q3 and now exceeds 50% of business mix. Robust free cash flow margins (>30%) and a 4.7% yield provide BMY investors with attractive compensation while awaiting pipeline catalysts.

image for news Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff